IMV Inc. (IMV) Press Releases https://www.imv-inc.com/investors/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/imvinc/files/theme/images/logo-sm.png IMV Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency]]> https://www.imv-inc.com/investors/press-releases/detail/747/imv-receives-nasdaq-notification-regarding-minimum-bid Fri, 31 Mar 23 16:15:00 -0400 https://www.imv-inc.com/investors/press-releases/detail/747/imv-receives-nasdaq-notification-regarding-minimum-bid <![CDATA[IMV Inc. Announces Changes to Its Board of Directors]]> https://www.imv-inc.com/investors/press-releases/detail/746/imv-inc-announces-changes-to-its-board-of-directors Mon, 27 Mar 23 16:15:00 -0400 https://www.imv-inc.com/investors/press-releases/detail/746/imv-inc-announces-changes-to-its-board-of-directors <![CDATA[IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results]]> https://www.imv-inc.com/investors/press-releases/detail/745/imv-inc-announces-strategic-update-as-well-as-fourth Thu, 16 Mar 23 07:05:00 -0400 https://www.imv-inc.com/investors/press-releases/detail/745/imv-inc-announces-strategic-update-as-well-as-fourth <![CDATA[IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023]]> https://www.imv-inc.com/investors/press-releases/detail/744/imv-inc-to-announce-fourth-quarter-and-fiscal-year-2022 Thu, 09 Mar 23 07:05:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/744/imv-inc-to-announce-fourth-quarter-and-fiscal-year-2022 <![CDATA[IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial]]> https://www.imv-inc.com/investors/press-releases/detail/743/imv-inc-presents-positive-initial-results-from-the-mvp-s Mon, 13 Feb 23 07:05:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/743/imv-inc-presents-positive-initial-results-from-the-mvp-s <![CDATA[IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S]]> https://www.imv-inc.com/investors/press-releases/detail/742/imv-inc-announces-update-and-planned-2023-milestones-to Sun, 08 Jan 23 17:00:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/742/imv-inc-announces-update-and-planned-2023-milestones-to <![CDATA[IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules]]> https://www.imv-inc.com/investors/press-releases/detail/741/imv-announces-closing-of-us9-million-registered-direct Tue, 20 Dec 22 12:37:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/741/imv-announces-closing-of-us9-million-registered-direct <![CDATA[IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules]]> https://www.imv-inc.com/investors/press-releases/detail/740/imv-announces-us9-million-registered-direct-offering Fri, 16 Dec 22 08:00:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/740/imv-announces-us9-million-registered-direct-offering <![CDATA[IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL]]> https://www.imv-inc.com/investors/press-releases/detail/739/imv-inc-announces-initial-data-from-the-ongoing-phase-2b Thu, 15 Dec 22 07:05:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/739/imv-inc-announces-initial-data-from-the-ongoing-phase-2b <![CDATA[IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split]]> https://www.imv-inc.com/investors/press-releases/detail/738/imv-commences-trading-on-the-tsx-and-nasdaq-post-reverse Tue, 13 Dec 22 07:05:00 -0500 https://www.imv-inc.com/investors/press-releases/detail/738/imv-commences-trading-on-the-tsx-and-nasdaq-post-reverse